KALA HAYNES: Open Payments
NPI 1508171315 · ORMOND BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,061 in 43 payments from 13 companies in 2025. Trend: 2023 $922 · 2024 $1,260 · 2025 $1,061
Food & beverage: $1,024Education: $37
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 12 | $200 |
| Ardelyx, Inc. | 5 | $190 |
| Amgen Inc. | 5 | $140 |
| Vifor Pharma, Inc. | 4 | $113 |
| Calliditas Therapeutics US Inc. | 3 | $82 |
| AstraZeneca Pharmaceuticals LP | 3 | $69 |
| Fresenius USA Marketing, Inc. | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 2 | $61 |
| Mallinckrodt Hospital Products Inc. | 2 | $53 |
| ANI Pharmaceuticals, Inc. | 1 | $30 |
Products named: XPHOZAH 30 MG, Veltassa, TAVNEOS, TARPEYO, IBSRELA, FARXIGA, VELPHORO, JYNARQUE.
Industry payments across FL — which companies pay providers there.
